F. Javoy-Agid

Overview

Best Publications

• Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

  D. T. Dexter;C. J. Carter;F. R. Wells;F. Javoy-Agid

  1831
  Citations

• Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

  Jeswinder Sian;D. T. Dexter;A. J. Lees;S. Daniel

  1648
  Citations

• Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

  D. T. Dexter;A. Carayon;F. Javoy-Agid;Y. Agid

  1449
  Citations

• Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease

  P Anglade;S Vyas;F Javoy-Agid;M T Herrero

  1327
  Citations

• Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

  Bernard Scatton;Liliane Rouquier;Bruno Dubois

  1037
  Citations

• Mitochondrial defect in Huntington's disease caudate nucleus

  M. Gu;M. T. Gash;V. M. Mann;F. Javoy‐Agid

  887
  Citations

• Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

  G. Boka;P. Anglade;D. Wallach;F. Javoy-Agid

  813
  Citations

• Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

  E C Hirsch;A M Graybiel;C Duyckaerts;F Javoy-Agid

  748
  Citations

• Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X-Ray Microanalysis

  E. C. Hirsch;J.-P. Brandel;P. Galle;F. Javoy-Agid

  738
  Citations

• Glutathione peroxidase, glial cells and Parkinson's disease

  P. Damier;E.C. Hirsch;P. Zhang;Y. Agid

  576
  Citations

• Is the mesocortical dopaminergic system involved in Parkinson disease?

  Unknown

  443
  Citations

• A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics

  B Grima;A Lamouroux;C Boni;J F Julien

  440
  Citations

• Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.

  Merle Ruberg;Alain Ploska;Yves Agid

  377
  Citations

• Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.

  S Flament;A Delacourte;M Verny;J J Hauw

  334
  Citations

• Striatal dopamine deficiency in parkinson's disease: Role of aging

  Unknown

  314
  Citations

• [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy.

  B Bokobza;M Ruberg;B Scatton;F Javoy-Agid

  311
  Citations

• Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content?

  A. Kastner;E. C. Hirsch;O. Lejeune;F. Javoy-Agid

  310
  Citations

• Dopaminergic and cholinergic lesions in progressive supranuclear palsy

  M Ruberg;F Javoy-Agid;E Hirsch;B Scatton

  303
  Citations

• Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease.

  Gaspar P;Duyckaerts C;Alvarez C;Javoy-Agid F

  295
  Citations

• Parkinson's disease and dementia: Norepinephrine and dopamine in locus ceruleus

  R. Cash;T. Dennis;R. L'Heureux;R. Raisman

  281
  Citations

• Subthalamotomy in parkinsonian monkeys Behavioural and biochemical analysis

  J. Guridi;M. T. Herrero;M. R. Luquin;J. Guillén

  281
  Citations

• Dopamine deficiency in the cerebral cortex in Parkinson disease

  B. Scatton;L. Rouquier;F. Javoy-Agid;Y. Agid

  248
  Citations

• A subcortico-cortical cholinergic system is affected in Parkinson's disease

  B Dubois;M Ruberg;F Javoy-Agid;A Ploska

  248
  Citations

• Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease

  S Lehéricy;E C Hirsch;P Cervera-Piérot;L B Hersh

  245
  Citations